Lymphoma: all 5,623 studies
Page 1 of 57. Open to participants first (823), then studies with results posted, then the rest; newest registration first within each.
- Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI.Not yet recruitingNCT07883941Phase 1
- Bispecific Antibody-Based Holding/Bridging Therapy Before CAR-T in Aggressive B-Cell LymphomasRecruitingNCT07883135Phase 2
- A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell LymphomaNot yet recruitingNCT07882576
- Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell TherapyNot yet recruitingNCT07875413Phase 2
- Early Prophylactic rhTPO Administration for Thrombocytopenia Associated With EAP Regimen-Based Hematopoietic Stem Cell MobilizationNot yet recruitingNCT07848672Phase 2/3
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialNot yet recruitingNCT07820033Phase 2
- Proton Therapy for Mediastinal Lymphoma (PROMLY)RecruitingNCT07817641Not applicable
- Impact of Demography, Ethnicity, Co-morbidities and Inequalities on Outcomes in DLBCL Across the UKCHART NetworkNot yet recruitingNCT07813585
- A Study Of Remote Patient Monitoring (RPM) Program For Cancer Patients Initiating Cancer-directed TherapyNot yet recruitingNCT07810400Not applicable
- A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory LymphomaNot yet recruitingNCT07791615Phase 2
- Musculoskeletal Ultrasound in Patients With Hematologic MalignanciesNot yet recruitingNCT07785505
- CD38 Targeted -PET/ CT for Multiple MyelomaRecruitingNCT07782944Not applicable
- CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line TherapyRecruitingNCT07779018Phase 2
- Exploration of Circular RNA in B-cell Hematologic MalignanciesRecruitingNCT07774572Phase 1
- BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple MyelomaNot yet recruitingNCT07771361Phase 2
- Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsRecruitingNCT07763054
- Development and Dissemination of Exercise Prescription and Intervention for Cancer PopulationsRecruitingNCT07751783Not applicable
- Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in Hours, Not Days.Not yet recruitingNCT07739849Not applicable
- Rutgers University Study of the Genetics of Blood CancersRecruitingNCT07714044
- GLORY: Glofit-GemOx With Liso-Cel For LymphomaRecruitingNCT07711483Phase 2
- Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic MalignanciesNot yet recruitingNCT07710781Not applicable
- More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)RecruitingNCT07705178Not applicable
- Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07698080Phase 2
- Disease Evolution and Risk Factors of AIDS-related Prevalent CancersNot yet recruitingNCT07696169
- BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic MalignanciesNot yet recruitingNCT07679919Phase 1
- GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell LymphomaNot yet recruitingNCT07670260Early Phase 1
- The CARDIOPROTECT TrialRecruitingNCT07654426Phase 2
- Toxin Exposure and Immune Dysregulation in Non-Hodgkin LymphomaRecruitingNCT07652580
- Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods StudyNot yet recruitingNCT07634263
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsRecruitingNCT07628634Early Phase 1
- Digitalized Exercise Fit Tool Intervention for Adolescents With Blood CancerNot yet recruitingNCT07621887Not applicable
- R-PMDT Regimen in Newly Diagnosed PCNSLRecruitingNCT07604987Phase 2
- CD19/CD22 CAR-T as First-line Consolidation in Follicular LymphomaRecruitingNCT07587840Phase 2
- Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone LymphomaRecruitingNCT07583810Phase 2
- A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and LymphomaNot yet recruitingNCT07583771Phase 1
- Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityNot yet recruitingNCT07572175Phase 2
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX StudyNot yet recruitingNCT07558057
- Remote Monitoring and Symptom Management Digital ApplicationRecruitingNCT07553572Not applicable
- Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic TumorsNot yet recruitingNCT07539610Phase 1
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingNCT07524530Phase 2
- Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.Not yet recruitingNCT07518329Phase 1
- Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic LymphomaRecruitingNCT07513129Phase 1
- U96-CAR-T-Cells For R/R B-ALLNot yet recruitingNCT07511426Phase 1
- Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)RecruitingNCT07509151Phase 3
- TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell LymphomaNot yet recruitingNCT07502872Phase 2
- Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse EventEnrolling by invitationNCT07499128Not applicable
- HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy SurvivorsNot yet recruitingNCT07483749
- A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell MalignanciesNot yet recruitingNCT07476378Not applicable
- Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)RecruitingNCT07472972
- A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)RecruitingNCT07465835Phase 1
- Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZLRecruitingNCT07441993Phase 2
- Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyRecruitingNCT07426484Phase 4
- A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received BlinatumomabRecruitingNCT07422337
- This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including RNot yet recruitingNCT07412405Not applicable
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell ImmunotherapyRecruitingNCT07390071Not applicable
- CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant LymphomaNot yet recruitingNCT07383233Phase 1
- Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell LymphomaRecruitingNCT07356245Phase 2
- Diagnostic Value and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy Versus Transbronchial Needle Aspiration in the Diagnosis of Lymphoma: a Randomized Controlled TrialNot yet recruitingNCT07352267Not applicable
- A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive ChemotherapyNot yet recruitingNCT07335094Early Phase 1
- A Clinical Study of HX111 in Patients With Advanced Solid Tumor and LymphomaNot yet recruitingNCT07333469Phase 1/2
- A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic MalignanciesNot yet recruitingNCT07316907Phase 1
- Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)RecruitingNCT07309497
- GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid NeoplasmsRecruitingNCT07306156Phase 1/2
- Randomised Controlled Trial of Artificial Intelligence-assisted Health EducationRecruitingNCT07305337Not applicable
- A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)RecruitingNCT07302347Phase 1/2
- CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBLRecruitingNCT07294677Phase 1/2
- Survivors Uniting for Remote Guided ExerciseRecruitingNCT07290309Not applicable
- Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T TherapyNot yet recruitingNCT07289087
- Precision Physical Exercise for Personalized Onco-Hematology.Not yet recruitingNCT07286539Not applicable
- Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell LymphomaRecruitingNCT07285590Phase 2
- Shanghai Lymphoma Clinical CohortNot yet recruitingNCT07285174
- Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT07284433Phase 1/2
- To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCTRecruitingNCT07280494Phase 1
- Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesRecruitingNCT07270263Not applicable
- Use of Preoperative Postbiotic Supplementation in Colorectal Cancer SurgeryRecruitingNCT07268846Not applicable
- PET-CT in Lymphoma Among the ElderyNot yet recruitingNCT07259941
- Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell LymphomaRecruitingNCT07254754Phase 2
- Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaRecruitingNCT07249905Phase 1/2
- Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.Not yet recruitingNCT07244380Phase 2
- An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic CancersRecruitingNCT07226934Not applicable
- A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)RecruitingNCT07221500Phase 2
- Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT AssessmentNot yet recruitingNCT07206264Phase 2
- High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)RecruitingNCT07205523
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)RecruitingNCT07202091Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)RecruitingNCT07202078Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)RecruitingNCT07202065Phase 2/3
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)RecruitingNCT07202052Phase 2/3
- Immune Adverse Events Registry in Onco-Hematologic Patients Treated With ImmunotherapyNot yet recruitingNCT07198958
- AI-assisted Diagnosis of Malignant Brain TumorsRecruitingNCT07198256
- A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaRecruitingNCT07192471Phase 1
- A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyRecruitingNCT07188558Phase 3
- xDRIVE for Florida-based Cancer PatientsRecruitingNCT07167381Not applicable
- Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph NodesRecruitingNCT07155954
- SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesRecruitingNCT07153068Phase 1/2
- HPC Offered for PRESERVE ExpansionRecruitingNCT07145411
- GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ LymphomaRecruitingNCT07138547Phase 1/2
- A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)RecruitingNCT07137494Phase 1
- A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell MalignanciesRecruitingNCT07135466Phase 1/2